메뉴 건너뛰기




Volumn 63, Issue 2, 1995, Pages 231-237

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT VACCINE;

EID: 0028846857     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910630215     Document Type: Article
Times cited : (104)

References (30)
  • 1
    • 0027447614 scopus 로고
    • Prostate‐specific antigen: biochemistry, analytical methods and clinical application
    • (1993) Clin. Chem. , vol.39 , pp. 181-195
    • Armbruster, D.A.1
  • 16
    • 0027205375 scopus 로고
    • Comparison of a CEA‐recombinant vaccinia virus, purified CEA and an anti‐idiotype antibody bearing the image of a CEA epitope in the treatment and prevention of CEA‐expressing tumors
    • (1993) Vaccine Res. , vol.2 , pp. 79-94
    • Irvine, K.1    Kantor, J.2    Schlom, J.3
  • 24
    • 0022964876 scopus 로고
    • Vaccinia virus vectors utilizing the β‐galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression
    • (1986) Gene , vol.47 , pp. 193-199
    • Panicali, D.1    Grzelecki, A.2    Huang, C.3
  • 26
    • 84991142492 scopus 로고
    • In vitro immunization of human cytotoxic T lymphocytes specific for peptides derived from prostate specific antigen [Abstract #M16]. Cancer Vaccines: Structural Basis for Vaccine Development, October 3–5, 1994, New York, NY, USA
    • (1994)
    • Peace, D.J.1    Xue, B.2    Sosman, J.A.3    Zhang, Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.